🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

Oracle shareholders elect board, approve executive pay, and ratify accounting firm

Published 18/11/2024, 22:02
ORCL
-

In a recent shareholder meeting, Oracle Corp . (NYSE:ORCL) successfully elected its slate of director nominees and approved executive compensation, according to an 8-K filing with the U.S. Securities and Exchange Commission. The meeting, held on Thursday, also saw the ratification of Ernst & Young LLP as the company's independent auditor for the upcoming fiscal year.

During Oracle's 2024 Annual Meeting on November 14, shareholders voted in favor of all director nominees, who will serve until the 2025 Annual Meeting. The directors include Oracle veterans such as Safra A. Catz, Lawrence J. Ellison, and Jeffrey O. Henley, alongside other business leaders. The advisory vote on executive compensation passed with over 1.8 billion shares in favor, reflecting shareholder support for the company's leadership pay structure.

The appointment of Ernst & Young LLP for the fiscal year ending May 31, 2025, was ratified with a significant majority, garnering over 2.5 billion shares in favor. This endorsement underscores investor confidence in the firm's ability to conduct Oracle's financial audits.

However, a shareholder proposal requesting a report on climate risks to retirement plan beneficiaries did not pass, with over 2.1 billion shares against it. The proposal's defeat indicates that the majority of shareholders may not see this as a priority for the software giant at this time.

In other recent news, Oracle Corporation (NYSE:ORCL) has seen significant developments in its operations and financial performance. The company has expanded its partnership with NTT DATA Japan to enhance cloud service offerings using Oracle Alloy. The U.S. Army is also migrating its Integrated Personnel and Pay System-Army to the Oracle U.S. Defense Cloud, a move expected to result in substantial cost savings and improved HR and payroll efficiency.

Oracle has launched its Oracle Health Clinical Data Exchange, a cloud-based platform designed to streamline the exchange of medical claims information. On the financial front, Oracle has issued $6.25 billion in senior notes, with the net proceeds planned for debt repayment and potential future acquisitions.

Several analyst firms have updated their assessments of Oracle. HSBC (LON:HSBA) raised its price target for the company based on the strong performance of Oracle Cloud Infrastructure, while Erste Group upgraded Oracle from Hold to Buy, citing robust software offerings and expanding cloud infrastructure.

However, RBC Capital initiated coverage with a "Sector Perform" rating, expressing concerns about Oracle's cloud infrastructure segment's ability to compete effectively with industry giants such as Amazon (NASDAQ:AMZN) Web Services and Microsoft (NASDAQ:MSFT) Azure.

InvestingPro Insights

Oracle's recent shareholder meeting outcomes reflect the company's strong market position and investor confidence. This is further supported by InvestingPro data, which shows Oracle's impressive market capitalization of $513.01 billion. The company's financial health is evident in its revenue of $53.81 billion for the last twelve months as of Q1 2025, with a solid gross profit margin of 71.31%.

InvestingPro Tips highlight Oracle's consistent performance and shareholder value. The company has raised its dividend for 11 consecutive years and has maintained dividend payments for 16 years straight. This commitment to shareholder returns aligns with the positive vote on executive compensation at the recent meeting.

Oracle's stock performance has been particularly strong, with a 61.22% total return over the past year and a substantial 76.41% return year-to-date. The company is trading near its 52-week high, with its current price at 96.85% of that peak, indicating strong market optimism.

For investors seeking more comprehensive analysis, InvestingPro offers 17 additional tips on Oracle, providing deeper insights into the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.